Retroviral WASP gene transfer into human hematopoietic stem cells reconstitutes the actin cytoskeleton in myeloid progeny cells differentiated in vitro

Experimental Hematology

Volumn 34, Issue 9, 2006, Pages 1161-1169

  Dewey, Ricardo A ^a   Díez, Inés Avedillo ^a   Ballmaier, Matthias ^a   Filipovich, Alexandra ^b   Greil, Johann ^c   Güngör, Tayfun ^d   Happel, Christoph ^a   Maschan, Alexey ^e   Noyan, Fatih ^a   Pannicke, Ulrich ^f   Schwarz, Klaus ^f   Snapper, Scott ^g   Welte, Karl ^a   Klein, Christoph ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^c UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^d UNIVERSITY CHILDREN S HOSPITAL   (Switzerland)

^e Research Institute of Pediatric Hematology   (Russian Federation)

^f UNIVERSITY HOSPITAL ULM   (Germany)

^g MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIN; FC RECEPTOR; MESSENGER RNA; RETROVIRUS VECTOR; WISKOTT ALDRICH SYNDROME PROTEIN;

ARTICLE; BONE MARROW CELL; CELL DIFFERENTIATION; CONTROLLED STUDY; CYTOSKELETON; GENE TRANSFER; GENETIC TRANSDUCTION; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; PHAGOCYTOSIS; PRIORITY JOURNAL; STEM CELL GENE THERAPY; TOXICITY; VIRAL GENE DELIVERY SYSTEM; VIRAL GENE THERAPY; WISKOTT ALDRICH SYNDROME;

ANTIGENS, CD14; ANTIGENS, CD34; CELL DIFFERENTIATION; CELLS, CULTURED; GENE THERAPY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; MICROFILAMENTS; MYELOID PROGENITOR CELLS; PHAGOCYTOSIS; RECEPTORS, IGG; TRANSDUCTION, GENETIC; WISKOTT-ALDRICH SYNDROME; WISKOTT-ALDRICH SYNDROME PROTEIN;

EID: 33747883767     PISSN: 0301472X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.exphem.2006.04.021     Document Type: Article

References (30)

1. Ochs H.D., and Rosen F.S. The Wiskott-Aldrich syndrome. In: Ochs H., Smith C., and Puck J. (Eds). Primary Immunodeficiency Diseases: A Molecular and Genetic Approach (1999), Oxford University Press, New York 292-305
2. Derry J.M., Ochs H.D., and Francke U. Isolation of a novel gene mutated in Wiskott Aldrich syndrome. Cell 78 (1994) 635-644
3. Thrasher A.J. WASp in immune-system organization and function. Nat Rev Immunol 2 (2002) 635-646
4. Burns S., Cory G.O., Vainchenker W., and Thrasher A.J. Mechanisms of WASp-mediated hematologic and immunologic disease. Blood 104 (2004) 3454-3462
5. Sullivan K.E., Mullen C.A., Blaese R.M., and Winkelstein J.A. A multi-institutional survey of the Wiskott-Aldrich syndrome. J Pediatr 125 (1994) 876-885
6. Parkman R., Rappeport J., Geha R., et al. Complete correction of the Wiskott-Aldrich syndrome by allogeneic bone-marrow transplantation. N Engl J Med 298 (1978) 921-927
7. Ozsahin H., Le Deist F., Benkerrou M., et al. Bone marrow transplantation in 26 patients with Wiskott-Aldrich syndrome from a single center. J Pediatr 129 (1996) 238-244
8. Filipovich A.H., Stone J.V., Tomany S.C., et al. Impact of donor type on outcome of bone marrow transplantation for Wiskott-Aldrich syndrome: collaborative study of the International Bone Marrow Transplant Registry and the National Marrow Donor Program. Blood 97 (2001) 1598-1603
9. Candotti F., Facchetti F., Blanzuoli L., et al. Retrovirus-mediated WASP gene transfer corrects defective actin polymerization in B cell lines from Wiskott-Aldrich syndrome patients carrying 'null' mutations. Gene Ther 6 (1999) 1170-1174
10. Huang M.M., Tsuboi S., Wong A., et al. Expression of human Wiskott-Aldrich syndrome protein in patients' cells leads to partial correction of a phenotypic abnormality of cell surface glycoproteins. Gene Ther 7 (2000) 314-320
11. Wada T., Jagadeesh G.J., Nelson D.L., and Candotti F. Retrovirus-mediated WASP gene transfer corrects Wiskott-Aldrich syndrome T-cell dysfunction. Hum Gene Ther 13 (2002) 1039-1046
12. Strom T.S., Gabbard W., Kelly P.F., Cunningham J.M., and Nienhuis A.W. Functional correction of T cells derived from patients with the Wiskott-Aldrich syndrome (WAS) by transduction with an oncoretroviral vector encoding the WAS protein. Gene Ther 10 (2003) 803-809
13. Dupre L., Trifari S., Follenzi A., et al. Lentiviral vector-mediated gene transfer in T cells from Wiskott-Aldrich syndrome patients leads to functional correction. Mol Ther 10 (2004) 903-915
14. Jones G.E., Zicha D., Dunn G.A., Blundell M., and Thrasher A. Restoration of podosomes and chemotaxis in Wiskott-Aldrich syndrome macrophages following induced expression of WASp. Int J Biochem Cell Biol 34 (2002) 806-815
15. Burns S., Thrasher A.J., Blundell M.P., Machesky L., and Jones G.E. Configuration of human dendritic cell cytoskeleton by Rho GTPases, the WAS protein, and differentiation. Blood 98 (2001) 1142-1149
16. Klein C., Nguyen D., Liu C.H., et al. Gene therapy for Wiskott-Aldrich syndrome: rescue of T-cell signaling and amelioration of colitis upon transplantation of retrovirally transduced hematopoietic stem cells in mice. Blood 101 (2003) 2159-2166
17. Strom T.S., Turner S.J., Andreansky S., et al. Defects in T-cell-mediated immunity to influenza virus in murine Wiskott-Aldrich syndrome are corrected by oncoretroviral vector-mediated gene transfer into repopulating hematopoietic cells. Blood 102 (2003) 3108-3116
18. Charrier S., Stockholm D., Seye K., et al. A lentiviral vector encoding the human Wiskott-Aldrich syndrome protein corrects immune and cytoskeletal defects in WASP knockout mice. Gene Ther 12 (2005) 597-606
19. Klein C., Bueeler H.R., and Mulligan R.C. Comparative analysis of genetically modified dendritic cells and cytokine transduced tumor cells as therapeutic cancer vaccines. J Exp Med 191 (2000) 1699-1708
20. Ory D.S., Neugeboren B.A., and Mulligan R.C. A stable human-derived packaging cell line for production of high titer retrovirus/vesicular stomatitis virus G pseudotypes. Proc Natl Acad Sci U S A 93 (1996) 11400-11406
21. Martin F., Toscano M.G., Blundell M., et al. Lentiviral vectors transcriptionally targeted to hematopoietic cells by WASP gene proximal promoter sequences. Gene Ther 12 (2005) 715-723
22. Linder S., Nelson D., Weiss M., and Aepfelbacher M. Wiskott-Aldrich syndrome protein regulates podosomes in primary human macrophages. Proc Natl Acad Sci U S A 96 (1999) 9648-9653
23. Baum C., Dullmann J., Li Z., et al. Side effects of retroviral gene transfer into hematopoietic stem cells. Blood 101 (2003) 2099-2114
24. Symons M., Derry J.M., Karlak B., et al. Wiskott-Aldrich syndrome protein, a novel effector for the GTPase CDC42Hs, is implicated in actin polymerization. Cell 84 (1996) 723-734
25. Snapper S., Takeshima F., Anton I., et al. N-WASP-deficiency reveals distinct pathways for cell surface projections and the actin-based motility of intracellular microorganisms. Nat Cell Biol 3 (2001) 898-904
26. Lorenzi R., Brickell P.M., Katz D.R., Kinnon C., and Thrasher A.J. Wiskott-Aldrich syndrome protein is necessary for efficient IgG-mediated phagocytosis. Blood 95 (2000) 2943-2946
27. Snapper S.B., Meelu P., Nguyen D., et al. WASP deficiency leads to global defects of directed leukocyte migration in vitro and in vivo. J Leukoc Biol 77 (2005) 993-998
28. Wengler G., Gorlin J.B., Williamson J.M., Rosen F.S., and Bing D.H. Non-random inactivation of the X chromosome in early lineage hematopoietic cells in carriers of Wiskott-Aldrich syndrome. Blood 85 (1995) 2471-2477
29. Lacout C., Haddad E., Sabri S., et al. A defect in hematopoietic stem cell migration explains the nonrandom X-chromosome inactivation in carriers of Wiskott-Aldrich syndrome. Blood 102 (2003) 1282-1289
30. Yamaguchi K., Ariga T., Yamada M., et al. Mixed chimera status of 12 patients with Wiskott-Aldrich syndrome (WAS) after hematopoietic stem cell transplantation: evaluation by flow cytometric analysis of intracellular WAS protein expression. Blood 100 (2002) 1208-1214